Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


18.02.2019

1 Am J Obstet Gynecol
1 Ann Oncol
1 Gynecol Oncol
1 Hum Pathol
1 Int J Gynaecol Obstet
1 J Natl Cancer Inst
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. CHAM S, Chen L, St Clair CM, Hou JY, et al
    Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2019 Feb 13. pii: S0002-9378(19)30360.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. LIU JF, Barry WT, Birrer M, Lee JM, et al
    Overall survival and updated progression-free survival outcomes in a randomized phase 2 study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
    Ann Oncol. 2019 Feb 7. pii: 5308594. doi: 10.1093.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  3. NAUMANN RW, Coleman RL, Brown J, Moore KN, et al
    Phase III trials in ovarian cancer: The evolving landscape of front line therapy.
    Gynecol Oncol. 2019 Feb 12. pii: S0090-8258(19)30113.
    PubMed     Text format     Abstract available


    Hum Pathol

  4. ROY M, Connor J, Al-Niaimi A, Rose SL, et al
    Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
    Hum Pathol. 2018;73:1-6.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  5. LEE DY, Kim HJ, Lee JY, Choi D, et al
    Usefulness of repeat pelvic ultrasonography before surgery for benign ovarian mass.
    Int J Gynaecol Obstet. 2018 Nov 8. doi: 10.1002/ijgo.12708.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  6. DIXON-SUEN SC, Webb PM, Wilson LF, Tuesley K, et al
    The Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study.
    J Natl Cancer Inst. 2019 Feb 11. pii: 5308404. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  7. JOHN B, Naczki C, Patel C, Ghoneum A, et al
    Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    Oncogene. 2019 Feb 14. pii: 10.1038/s41388-019-0728.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: